<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01264900</url>
  </required_header>
  <id_info>
    <org_study_id>MH086525</org_study_id>
    <nct_id>NCT01264900</nct_id>
  </id_info>
  <brief_title>Cognitive Behavioral Aggression Treatment</brief_title>
  <official_title>Cognitive Behavioral Aggression Treatment: Effects on Brain and Behavior</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Temple University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Temple University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aggressive behavior is a leading worldwide public health problem. Despite this, relatively&#xD;
      little is known about how to best treat individuals who are highly angry and aggressive. A&#xD;
      rich literature suggests that aggression is associated with a tendency to interpret&#xD;
      situations as threatening or hostile even when they are not. This process is governed by a&#xD;
      prefrontal-limbic circuit in the brain. A goal of cognitive behavioral therapy is to reduce&#xD;
      these kinds of hostile biases. Preliminary data by the PI suggests a 12- session cognitive&#xD;
      behavioral aggression treatment (CBAT) may help reduce aggressive behavior and underlying&#xD;
      hostile biases associated with affective aggression. To assess the efficacy of this&#xD;
      treatment, 120 adults with high levels of anger and aggression will receive 12 sessions of&#xD;
      either CBAT or supportive psychotherapy. All subjects will monitor their anger and aggressive&#xD;
      behavior throughout the treatment electronic diaries. Subjects will also complete&#xD;
      questionnaires and computer tasks to assess anger, hostile biases and related processes&#xD;
      1-week before treatment begins, and again 1-week, 6-months and 1-year after treatment ends.&#xD;
      In addition, to understand the effects of CBAT on the brain, subjects will have their brains&#xD;
      scanned (functional Magnetic Resonance Imaging) while they look at emotional pictures and&#xD;
      complete computer tasks. The brain scans will occur once before treatment starts and once&#xD;
      after treatment ends.&#xD;
&#xD;
      Our hypotheses are:&#xD;
&#xD;
        1. CBAT will reduce anger, aggression and hostile biases more than supportive therapy.&#xD;
&#xD;
        2. CBAT will decrease limbic activation and increase prefrontal activation to emotional&#xD;
           pictures more than supportive therapy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Aggressive Acts</measure>
    <time_frame>Pre-intervention thru 1 year post-intervention</time_frame>
    <description>Aggressive acts will be measured using electronic diaries and clinical interview</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Brain activation to emotional stimuli</measure>
    <time_frame>14 weeks</time_frame>
    <description>Brain response (as measured by fMRI)to emotional expressions and pictures</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Aggression</condition>
  <arm_group>
    <arm_group_label>Cognitive Behavioral Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Twelve weekly 50-minute sessions of individual cognitive behavioral aggression treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Supportive Psychotherapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Twelve weekly 50-minute sessions of individual supportive (client-centered) psychotherapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Psychotherapy</intervention_name>
    <description>Twelve weekly 50-minute sessions of individual cognitive behavioral aggression treatment or supportive psychotherapy</description>
    <arm_group_label>Cognitive Behavioral Therapy</arm_group_label>
    <arm_group_label>Supportive Psychotherapy</arm_group_label>
    <other_name>CBT</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Three or more acts of physical aggression (assault / property destruction) in past six&#xD;
             months&#xD;
&#xD;
          -  Aggression related distress and/or impairment&#xD;
&#xD;
          -  Meets Criteria for Intermittent Explosive Disorder&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Life History of DSM-IV Axis Bipolar disorder, Schizophrenia, Delusional disorder,&#xD;
             Organic disorder, or Mental Retardation&#xD;
&#xD;
          -  Current DSM-IV Major Depressive Episode, Alcohol Dependence or other Drug Dependence&#xD;
&#xD;
          -  Current (past month) psychotropic medication use&#xD;
&#xD;
          -  Current severe suicidal or homicidal ideation necessitating immediate medical&#xD;
             intervention&#xD;
&#xD;
          -  Current pregnancy or nursing, or existence of any medical condition that would deem&#xD;
             the subject ineligible to undergo an fMRI (e.g., metal pins)&#xD;
&#xD;
          -  Two consecutive positive Expired Breathalyzer Alcohol or Urine Drug toxicological&#xD;
             screens&#xD;
&#xD;
          -  Unable or unwilling to cooperate with study protocol (e.g., keep appointments,&#xD;
             complete rating forms, read and understand informed consent).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael S McCloskey, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Temple University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Temple University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>McCloskey MS, Noblett KL, Deffenbacher JL, Gollan JK, Coccaro EF. Cognitive-behavioral therapy for intermittent explosive disorder: a pilot randomized clinical trial. J Consult Clin Psychol. 2008 Oct;76(5):876-86. doi: 10.1037/0022-006X.76.5.876.</citation>
    <PMID>18837604</PMID>
  </reference>
  <verification_date>March 2016</verification_date>
  <study_first_submitted>December 20, 2010</study_first_submitted>
  <study_first_submitted_qc>December 20, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 22, 2010</study_first_posted>
  <last_update_submitted>March 3, 2016</last_update_submitted>
  <last_update_submitted_qc>March 3, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 4, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Temple University</investigator_affiliation>
    <investigator_full_name>Michael McCloskey</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Psychotherapy</keyword>
  <keyword>Cognitive Behavioral Therapy</keyword>
  <keyword>Aggression</keyword>
  <keyword>fMRI</keyword>
  <keyword>Behavioral Intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aggression</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

